Picture of Lucid Diagnostics logo

LUCD Lucid Diagnostics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSucker Stock

Brief: Lucid Diagnostics Says Qtrly Loss Per Share $0.47

March 13 (Reuters) - Lucid Diagnostics Inc  LUCD.O :
    * LUCID DIAGNOSTICS PROVIDES BUSINESS UPDATE AND FOURTH
QUARTER
AND FULL YEAR 2022 FINANCIAL RESULTS
    * LUCID DIAGNOSTICS INC - QTRLY LOSS PER SHARE $0.47
    * LUCID DIAGNOSTICS INC - QTRLY ADJUSTED LOSS PER SHARE
$0.33
    * COMPANY SECURES FINANCING OF $24.6 MILLION THROUGH
SEPARATE
OFFERINGS OF PREFERRED STOCK AND DEBT, CONVERTIBLE AFTER
SEPTEMBER 2023
    * SIGNS IN-NETWORK AGREEMENT WITH LARGEST SECONDARY PPO,
MULTIPLAN, EXPANDING PATIENT ACCESS TO ESOGUARD
    * Q4 EARNINGS PER SHARE VIEW $-0.38 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nPn2qrqsxa 
Further company coverage:  LUCD.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Lucid Diagnostics

See all news